2009 BIO International Convention Exhibitor Profiles

Business Wire is the official news wire for the 2009 BIO International Convention. Breaking news releases, advisories, photos, and multimedia are available at Tradeshownews.com, Business Wire's trade show, conference, and event news resource.

Listed below are the 2009 BIO International Convention exhibitor profiles.

Company:                   ACR Image Metrix
Booth:                     5442
Media Contact:             Shawn Farley, Public Relations Manager
Phone:                     703-648-8936
E-mail:                    sfarley@acr.org
Web:                       www.acr-imagemetrix.net
ACR Image Metrix, located in the American College of Radiology
Clinical Research Center, applies imaging techniques as a predictive
and prognostic biomarker improving the efficiency for drug and
device development programs. The world-class team of physicians and
scientists at ACR Image Metrix work with pharmaceutical, biotech and
medical device companies to increase the efficiency of drug and
device development programs by integrating the appropriate imaging
modalities. ACR Image Metrix has years of experience and proven
expertise in employing state-of-the-art technologies provide a
complete line of imaging services.
Company:                   Allon Therapeutics Inc.
Ticker Symbol & Exchange:  TSX:NPC
Media Contact:             Aaron Keay, Director, Investor Relations
Phone:                     (604) 742-2540
E-mail:                    akeay@allontherapeutics.com
Web:                       www.allontherapeutics.com
VPO Press Kit URL:         http://www.virtualpressoffice.com/kit/AllonTherapeutics
Allon Therapeutics Inc. is a clinical-stage biotechnology company
developing treatments for major neurodegenerative conditions.
Allon's drug davunetide intranasal (AL-108) has demonstrated human
efficacy in amnestic mild cognitive impairment, a precursor to
Alzheimer's disease. Allon has Phase II human efficacy programs
pursuing large underserved markets: Alzheimer's disease,
frontotemporal dementia, and schizophrenia-related cognitive
impairment. The Company is listed on the Toronto Stock Exchange
under the trading symbol "NPC" (Neuro Protection CompanyTM) and
based in Vancouver.
Company:                   Alzheimer's Drug Discovery Foundation
Booth:                     W10
Media Contact:             Filomena Machleder
Phone:                     212-901-8004
E-mail:                    fmachleder@alzdiscovery.org
Web:                       www.alzdiscovery.org
The Alzheimer's Drug Discovery Foundation (ADDF) is the only public
charity whose sole mission is to rapidly accelerate the discovery
and development of drugs to prevent, treat and cure Alzheimer's
disease, related dementias and cognitive aging.
We raise and award funds to academic and biotechnology scientists
conducting drug discovery research in this field.
ADDF uses a venture philanthropy model to bridge the worldwide
funding gap between basic research and later-stage development,
using any return on investment to support new research.
Company:                   Avecia Biologics
Booth:                     5325
Media Contact:             Bridget Hall
Phone:                     44 (0)1642 367320
E-mail:                    bridget.hall@avecia.com
Web:                       www.avecia.com
Avecia Biologics has announced it has received a Manufacturer's
Licence from the Medicines and Healthcare products Regulatory Agency
(MHRA). The Licence was granted in connection with a client's
Biologics Licence Application and comes three months after the
company successfully underwent its first FDA Pre-Approval
Inspection, with just one observation on FDA Form 483. The company
has been making GMP material for clinical development for over 10
years, and in 2003 opened its large-scale manufacturing facility at
its UK site. Avecia Biologics is a leader in contract process
development and manufacturing services for microbially-derived
biologics at all stages of the product pipeline.
Company:                   Bio Nebraska
Booth:                     3247
Media Contact:             Amy Recker
Phone:                     (402) 829-9011
E-mail:                    arecker@bionebraska.org
Web:                       www.bionebraska.org
Bio Nebraska is dedicated to the coordination and expansion of
bioscience activity in Nebraska through partnerships between
universities, industry and government. Nebraska organizations have
expertise in medical, agricultural, industrial, environmental and
food biosciences. Learn about the innovative research and
development being conducted at the University of Nebraska, the
University of Nebraska Medical Center and at the many innovative
companies that are located in our state. See what is happening in
Nebraska and learn about the economic incentives Nebraska provides
business and industry. Visit www.bionebraska.org for more
information.
Company:                   BioPharm Insight
Booth:                     5153
Media Contact:             Brian Smith
Phone:                     781-702-6938
E-mail:                    bsmith@infinata.com
Web:                       www.biopharminsight.com
BioPharm Insight is an online database providing the most
comprehensive information and forward-looking insight within the
Biotechnology and Pharmaceutical industry. Through our global
network of research analysts and Pharmawire Journalists, we provide
the competitive intelligence and in-depth data you need to make
faster, better, decisions. The BioPharm Insight Suite covers more
than 44,000 companies and over 159,000 drugs and medical devices
through all their life stages.
Company:                   Bio-Rad Laboratories
Booth:                     5415
Ticker Symbol & Exchange:  BIO and BIOb
Media Contact:             Tina Cuccia
Phone:                     510-741-1000
Web:                       www.bio-rad.com
Bio-Rad's Life Science Group develops, manufactures, and markets a
wide range of laboratory instruments, apparatus, and consumables
used for research in functional genomics, proteomics, and food
safety. The group ranks among the top five life science companies
worldwide, and maintains a solid reputation for quality, innovation,
and commitment to its customers. Bio-Rad's life science products are
based on technologies used to separate, purify, analyze, identify,
and amplify biological materials such as proteins and nucleic acids.
These technologies include electrophoresis, imaging, multiplex
immunoassay, chromatography, microbiology, bioinformatics, protein
function analysis, transfection, amplification, and real-time PCR.
Bio-Rad products support researchers in laboratories throughout the
world.
Company:                   Calibrate, Inc.
Booth:                     2116
Media Contact:             Rodger Lenhardt
Phone:                     919-929-3004
E-mail:                    rodger.lenhardt@pipetpeople.com
Web:                       www.pipetpeople.com
Calibrate, Inc.--The Pipet People(TM) was founded in 1983. Today we
provide "ON-SITE" and mail-in pipette calibration services to
laboratories throughout North America. And we're ISO 17025:2005
Accredited so that you can continue pipetting with confidence and
let us do the worrying about liquid measurement uncertainty and
traceability. Visit us on the web at www.pipetpeople.com to order
service and liquid handling products.
Company:                   Competitive Technologies, Inc.
Booth:                     4919
Ticker Symbol & Exchange:  NYSE Amex: CTT
Media Contact:             Johnnie D. Johnson, IR Services, LLC
Phone:                     860-434-2465
E-mail:                    jdjohnson@corpirservices.com
Web:                       www.competitivetech.net
Competitive Technologies, established in 1968, provides
distribution, technology transfer, sales and licensing services
focused on matching the needs of its customers with commercially
viable product or technology solutions. CTT is a global leader in
identifying, developing and commercializing innovative products and
technologies in life, electronic, nano and physical sciences
developed by universities, companies and inventors.
CTT has exclusive rights to a non-invasive pain therapy medical
device for rapid treatment of high-intensity oncologic and
neuropathic pain, including pain resistant to morphine and other
drugs. The device has FDA 510(k) clearance for US sales and Medical
Device CE certification for European sales.
Company:                   Emergent Technologies, Inc.
Booth:                     4633
Media Contact:             Sandra Oak
Phone:                     321.591.1508
E-mail:                    soak@nsightpr.com
Web:                       www.etibio.com
Emergent Technologies, Inc. (ETI) is a life sciences technology
investment and management company which provides early stage funding
and development for scientific discoveries originating at
universities and research institutions. The Company creates value by
transforming scientific breakthroughs into technology platforms with
multiple applications. ETI's unique innovation process enables the
Company to select promising scientific discoveries for development,
maximize the value of intellectual property and manage both cost and
risk associated with the commercial development of early stage
technologies. ETI is dedicated to turning research into revenue and,
in the process, introducing compelling solutions to meet important
market needs.
Company:                   Eurofins Scientific
Booth:                     5211
Media Contact:             Bill Pfund
Phone:                     269-488-7016
E-mail:                    williampfund@eurofinsus.com
Web:                       www.avtechlabs.com
Eurofins Scientific's pharma division is a premium-class contract
service provider covering the entire spectrum of drug development
activities including the discovery, preclinical, clinical, and
production phases, with focus on early development, central
laboratory, and quality control services. We offer access to
state-of-the-art technology and high laboratory capacity across the
globe. Eurofins Pharma Services has a deep understanding of the
processes involved in pharmaceutical R&D and solid expertise in
regulatory guidance and compliance. Our high growth rate is a
testament to the quality of our work and the confidence placed in us
by our clients.
Company:                 Formatech, Inc.
Booth:                   5308
Media Contact:           Stacey McDonald
Phone:                   978-725-9077
E-mail:                  smcdonald@formatech.com
Web:                     www.formatech.com
At Formatech, we help make new drugs happen... at the speed of science!
Formatech provides contract services that deliver unique solutions
to our client's product development/manufacturing challenges,
including: preformulation/formulation development of all common
dosage forms, cell culture/fermentation process development and
purification/downstream process optimization.
We have had excellent results developing biotherapeutic products.
We've developed many Ab formulations at concentrations up to 200
mg/mL and an orally bioavailable peptide formulation.
Our aseptic manufacturing facility produces liquid and lyophilized
dosage units for clinical supplies or small-scale commercial
products. Manufacturing support services include
compounding/formulation, diafiltration/concentration (UF/DF),
release testing, and full ICH Guideline Stability Programs.
Company:                 Gene Logic
Booth:                   4817
Media Contact:           Dhanya Menon
Phone:                   91-40-66627200
E-mail:                  pr@ocimumbio.com
Web:                     www.genelogic.com
Gene Logic offers a range of world class solutions for clinical
genomics, biomarker discovery and validation, genomic data
analysis, latest platforms and protocol for gene expression
profiling, SNP genotyping, gene expression reference suites
BioExpress(R), ASCENTA(R) and ToxExpress(R), and life science Lab
Information Management Systems. Our expertise, global
infrastructure, large capacity, standardized procedures and highly
skilled staff make it one of a handful of preferred outsourcing
partners global pharmaceutical companies choose for genomics
outsourcing. Our genomic solutions support an array of drug
development programs such as pre-clinical target development,
toxicogenomic analysis, clinical biomarker identification, patient
stratification and pharmacogenomics.
Company:                 Greater Portland, Maine
Booth:                   4348
Media Contact:           Nelle Hanig
Phone:                   207-756-8019
E-mail:                  nrh@portlandmaine.gov
Web:                     www.greaterportland.org
The Greater Portland region is Maine's biotechnology hub. On the
spectacular Maine coast, we are home to one of Northern New
England's largest and fastest growing biotechnology clusters. Just
ten minutes from the Portland International Jetport and a two hour
drive from Boston, Greater Portland hosts world class research
institutes, diverse companies, universities, venture funds, public
financing that supports innovation and quality of life that is among
the best in the world.
Company:                 HollisterStier Contract Manufacturing
Booth:                   4805
Media Contact:           Shannon Jordan
Phone:                   509-482-4958
E-mail:                  Shannon_Jordan@hollister-stier.com
Web:                     HScontract.com
HollisterStier Contract Manufacturing are experts in the manufacture
of sterile injectables for the global pharmaceutical and
biopharmaceutical market. Cross-functional teams provide custom
solutions from development through commercialization. We offer
expert quality and project execution, a strong regulatory track
record and multiple processes under one roof. Hollister-Stier is
approved by the FDA/CDER/CBER and EU for manufacture of
Investigational Medicinal Products (IMPs). Current products produced
at HollisterStier consist of aqueous based diluents, oligonucleotide
products, small volume intravenous drug concentrates, small
molecular entities derived by chemical synthesis, recombinantly
produced products, and products derived from cell lines and
fermentation processes.
Company:                 Inhibikase Therapeutics
Booth:                   254, Georgia Pavil.
Media Contact:           Milton H. Werner, Ph.D., President & CEO
Phone:                   917 494 0831
E-mail:                  mhwerner@gmail.com
Inhibikase Therapeutics is a clinical and pre-clinical stage company
treating bacterial and viral infectious disease using a single
mechanism of action, often with the same pharmaceutical agent. The
Company's lead indication will revolutionize the treatment of flu
independent of flu strain, inhibiting pathways all flu viruses use
in the patient to drive reproduction in the host. The Company's
second indication will treat the AIDS-related disorder PML, a fatal
brain disorder afflicting patients with AIDS as well as patients who
have MS, lupus or who receive a kidney transplant. The Company's
stellar management team has 50+ years of combined drug development
experience, and will complete its first product and bring it to
market in under 5 years for less than $10MM, an unheard of metric
for product launch in the industry.
Company:                 InVivo BioTech Services GmbH
Booth:                   E-51
Media Contact:           Caterina Farnleitner
Phone:               49 (0) 3302 883 769
E-mail:              c.farnleitner@invivo.de
Web:                 www.invivo.de
As a Custom Manufacturing Organization (CMO) based in Hennigsdorf,
near Berlin InVivo is dedicated to the development and production of
monoclonal antibodies and the expression of recombinant proteins.
InVivo is an ISO9001 certified company with over ten years
experience in mammalian cell culture and protein production. As a
trusted provider of cost effective outsourcing solutions, InVivo has
been working for a large number of satisfied clients. Companies of
all sizes from small university spin-offs to major research
institutes and large established biopharmaceutical companies benefit
from our expertise as independent contract manufacturer.
We are open for any outsourcing projects in diagnostic or
pharmaceutical industry.
Company:             Kemwell Pvt Ltd
Media Contact:       Neha Bagaria
Phone:               91-80-3928-6200
E-mail:              neha.bagaria@kemwellpharma.com
Web:                 www.kemwellpharma.com
Kemwell is a contract development and manufacturing organization for
over 20 years with facilities in India and Sweden. We service some
of the top pharma companies of the world including Pfizer, GSK,
Bayer, Novartis, J&J etc. for their global needs.
We are in the process of building Green field facilities for the
development and manufacturing of biologic active substance and drug
product in a strategic alliance with Boehringer Ingelheim. The
facilities includes process development labs, cGMP manufacturing
facilities up to 2000L for microbial and mammalian cell systems, and
a fill & finish facility for aseptic liquid vial filling and
lyophilization.
Company:             Madeira Therapeutics
Booth:               3707(Kansas Bio)
Media Contact:       Pete Joiner
Phone:               (913) 661-1962
E-mail:              pjoiner@madeiratherapeutics.com
Web:                 www.madeiratherapeutics.com
VPO Press Kit URL:   http://www.virtualpressoffice.com/kit/Madeira
Madeira Therapeutics, LLC, is a specialty pharmaceutical company
focused on providing safe and effective medicine to pediatric and
geriatric patients, parents and the healthcare professionals that
serve them. The Madeira strategy focuses on reformulating adult
drugs for better dosage control in children. Madeira utilizes the
FDA's 505(b)(2) approval method, which shortcuts the FDA approval by
years, saving tens of millions of dollars in development costs. The
company's lead program, MT-001, is the first ever liquid preparation
of a statin developed for the geriatric and pediatric population.
The second product is MT-003 for acute pain relief.
Company:             Massachusetts Biotechnology Council
Booth:               2803
Media Contact:       Sarah MacDonald
Phone:               617-997-8641
E-mail:              sarah.macdonald@massbio.org
Web:                 www.massbio.org
The Massachusetts Biotechnology Council (MBC), a not-for-profit
organization that represents and provides services and support for
the Massachusetts biotechnology industry, is the nation's oldest
biotechnology trade association. Founded in 1985, the MBC is
committed to advancing the development of critical new science,
technology and medicines that benefit patients worldwide.
Representing over 600 biotechnology companies, academic
institutions, research hospitals, and service organizations involved
in life sciences and health care, the MBC works to advance policy
and promote education, while providing members with relevant
professional and business development opportunities, special events,
industry information, and services.
Company:             Medicel
Booth:               4713
Media Contact:       Jarno Makinen
Phone:               358 20 719 9477
E-mail:              jarno.makinen@medicel.com
Web:                 www.medicel.com
Medicel is a privately held biotechnology company. Medicel is a
bioreactor system supplier for the research community in the fields
of biology, medicine and pharmacology.
Medicel Explorer Parallel Bioreactor system with 15 fully
instrumented bioreactors for high throughput cell cultivation and
fermentation experiments. Bioreactor system combines parallel cell
cultivations, automatic sampling, in line analysis and rapid
perturbations. The compact size of our 15 bioreactor system and the
working volume range from 100mL to 500mL makes this an ideal high
throughput research platform.
Company:             Meissner Filtration Products, Inc.
Booth:               4800
Media Contact:       Karisa Koenig
Phone:                 805-388-9911
E-mail:                karisa.koenig@meissner.com
Web:                   www.meissner.com
From R&D through production, Meissner offers optimized filtration
and fluid management solutions for your process. Meissner Technical
Services (MTS) provides extensive validation services and support.
Visit booth #4800 to see our One-Touch(TM) single-use systems,
including TepoFlex(TM) biocontainers in 2D end- or face-ported
configurations, and 3D configurations with optional FlexStation(TM)
rigid outer containers. Also featured, membrane filters (0.04-1.0
um), including: SteriLUX(R) & Steridyne(R) PVDF, STyLUX(R) & EverLUX(TM) PES,
Chemdyne(R) PP and Ultradyne(R) PTFE. Microfiber prefilters and depth
filters are also offered (to 99 um.) Configurations include syringe
filters, discs, capsules, high-capacity UltraCap(R)/UltraCap(R) H.D.
(Heavy Duty) capsules, and cartridges.
Company:               MPI Research
Booth:                 5223
Media Contact:         Lisa Lambertsen
Phone:                 269.668.3336
E-mail:                lisa.lambertsen@mpiresearch.com
Web:                   www.mpiresearch.com
MPI Research is a full service Contract Research Organization that
partners with biotech, pharmaceutical, medical device, animal
health, and agrichemical companies in meeting their preclinical and
early clinical drug development research needs. From single study
protocols to seamless access to our broad scope of services, we work
with you to bring your products to market as expeditiously as
possible. We are known for our state-of-the-art facilities,
excellent study quality, regulatory familiarity, and GLP/cGMP
compliance and we measure our success by the quality of each Sponsor
contact. With MPI Research, you'll get results! For complete
information, visit our website at www.mpiresearch.com.
Company:               NanoImaging Services, Inc.
Booth:                 E-50
Media Contact:         Kay Wright
Phone:                 888-675-8261 ext 302
E-mail:                kwright@nanoimagingservices.com
Web:                   www.nanoimagingservices.com
Founded in 2007, NanoImaging Services provides nanoparticle
characterization services for use in early and late stage drug
development processes for pharmaceutical, biotech and nanotechnology
communities. NanoImaging Services specializes in direct
visualization of nanoscale samples such as: proteins & protein
complexes, liposomes & emulsions, viruses & virus like particles and
other nanoscale particles in solution. NanoImaging Services can help
to determine morphology characterization, particle assembly
assessment and 3D structure for your samples which can be useful in
the following applications: drug development, regulatory review and
validation. All images and data are immediately available to the
customer on a secure internet portal for long-term comparisons or
verifications. Contact us about your imaging needs at
info@nanoimagingservices.com.
Company:               OmegaChem
Media Contact:         David Gauthier
Phone:                 418-837-4444
E-mail:                davidgauthier@omegachem.com
Web:                   www.omegachem.com
OmegaChem is a privately owned Canadian company, located in the
Quebec City Area, in Canada.
We specialize in providing the chemical, and particularly the
pharmaceutical industry, with our expertise in sourcing, developing
and producing custom made intermediates, building blocks, synthons
and chirons, as well as supplying a wide range of fine chemicals.
Our activities serve customers located in over 30 countries
worldwide.
Our main field of expertise covers the development and production of
natural amino acid derivatives, functionalized heterocycles,
building blocks, specialty reagents, chiral auxiliaries but also a
large number of new and innovative fluorinated compounds. In
addition to our catalog of products, we develop new compounds for
our business partners, as part of CRO, custom synthesis or FTE.
Visit our website for more information: www.omegachem.com
Company:               Perkins Coie LLP
Booth:                 2826
Media Contact:         Julie Kaplan
Phone:                 310.788.3287
E-mail:                jlkaplan@perkinscoie.com
Web:                   www.perkinscoie.com
Perkins Coie is a leading international law firm, with 700+
attorneys throughout the U.S. and Asia, serving clients ranging from
Fortune 100 companies to startups. We employ a multidisciplinary
approach to provide a range of legal services to Life Sciences
companies at every stage of growth.
Company:               Quertle
Booth:                 E-52
Media Contact:         Vicki Burnett
E-mail:                info@quertle.com
Web:                   www.quertle.info
Quertle(R) is committed to providing innovative ways for researchers
to search and investigate the biomedical literature.
www.quertle.info provides a way to ask a question and get answers in
context, as well as a simple way to navigate what can often be an
overwhelming list of documents. Created by scientists, for
scientists, www.quertle.info uses cutting-edge, biology-aware text
analytics to dramatically reduce the time and effort required to
understand the literature.
Company:           Savitz Law Offices, P.C.
Booth:             5135
Media Contact:     Bennett Savitz
Phone:             (617)723-7111
E-mail:            bsavitz@immigrationoptions.com
Web:               www.immigrationoptions.com
Savitz Law Offices, P.C. (ImmigrationOptions.com) provides legal
services and expertise in all areas of immigration law both for
corporate clients and individuals. In addition to obtaining
temporary visas and permanent residence (Green Card) for foreign
nationals, we help clients to file to become naturalized U.S.
Citizens, and to solve specific problems with the Immigration
Service or other government agencies. We have extensive experience
working with the myriad of government entities involved in
immigration matters, and have developed a worldwide network of
contacts and other resources in order to assist our clients on any
matter, from the routine to the extraordinary.
Company:           The Scientist
Booth:             2834
Media Contact:     Stephanie Eaves
Phone:             215-351-1660
E-mail:            seaves@the-scientist.com
Web:               www.the-scientist.com
The Scientist, the award winning magazine of the life sciences, has
informed global life science professionals for over 22 years. We
provide our print and online readers with coverage of the latest
developments in research, technology, business, careers, and news.
We reach the leaders in academia and industry who are interested in
maintaining a broad view of the life sciences by reading insightful
articles that are current, concise and entertaining. For more
information about The Scientist, visit http://www.the-scientist.com.
Company:           Seagull Technology Pty Ltd
Booth:             6022
Media Contact:     Dr Shanny Dyer (Managing Director)
Phone:             61410 526 130
E-mail:            shanny.dyer@seagulltechnologies.com.au
Web:               www.seagulltechnologies.com.au
Seagull Technology has successfully delivered FDA approved drugs for
the treatment of Macular Degeneration and inflammatory diseases of
the eye without the need for injections.
The unique technology is a cross-platform, non-invasive drug and
biologic delivery system and device that utilizes a combination of
polymer-gels, nanotechnology and ultrasound.
The technology has potential for use in other organs and niche
applications in the Agribusiness and Cosmeceuticals sectors. The
company is interested to explore partnering with pharmaceutical
companies at BIO 2009.
The company has been invited to present its technology at the BIO
Business Forum and the Chairman, Dr Harry Unger, will address
attendees.
Company:           SK Life Science, Inc.
Media Contact:     Duncan Taylor
Phone:             (201) 421-3842
E-mail:            dtaylor@sklsi.com
Web:               www.sklsi.com
SK Life Science, Inc. is a global pharmaceutical company with over
170 employees at facilities in Fair Lawn, NJ; Seoul and Daejon,
Korea; and Shanghai, China. The company's focus over its 16 year
lifespan has been drug discovery and development for CNS diseases.
SK was the first Korean company with an approved US IND and has
successfully filed an additional six INDs for studies in anxiety,
depression, epilepsy, neuropathic pain, and schizophrenia. Through a
partner, J&J, an NDA for our lead compound carisbamate (YKP509) for
epilepsy was filed in the US in December 2008. Further details are
available at www.sklsi.com.
Company:           Solvias Inc.
Booth:             5514
Media Contact:     Silke Oeschger
Phone:             41 61 686 61 41
E-mail:            silke.oeschger@solvias.com
Web:               www.solvias.com
Solvias is a privately held company located in Basel/Switzerland.
With 280 highly qualified employees we support the research and
development of new drug substances and the optimization of
manufacturing processes for pharmaceutical and biotechnology
companies worldwide. Solvias' customers benefit from a wide range of
experience in catalysis, asymmetric synthesis, custom synthesis,
process R&D, polymorphism screening, salt selection, and analytical
services.
Solvias has an excellent reputation with global pharmaceutical
corporations for the characterization and QC analysis of monoclonal
antibodies and other protein biologics. However, small biotechnology
companies can gain access to the standards established by
market-leading biopharmaceutical companies. Contact us today!
Company:                   Sorbent Technologies Inc
Booth:                     5315
Media Contact:             Danielle Downs
Phone:                     678.222.0288
E-mail:                    ddowns@sorbtech.com
Web:                       www.sorbtech.com
Sorbent Technologies, Inc. brings a new understanding of value to
the scientific community. Through unparalleled selection, quality,
and service, Sorbent Technologies makes every grant and investment
dollar go further. Close relationships with the laboratories we
serve and the scientists who work in them ensure unique solutions
for method development and optimization. Our commitment to customer
service reflects our respect for laboratories, scientists, and the
pursuit of knowledge.
Visit our website to view our free applications database and top
quality life science products. With the efforts of supplies
purchasing shifted to Sobtech's shoulders, the laboratory can focus
on what's important: results.
Company:                   Spraying Systems Co
Booth:                     5714
Media Contact:             JoAnne Stapf
Phone:                     603-889-5000
E-mail:                    joanne.stapf@spray.com
Web:                       www.spray.com
As the world's expert in spray technology let us help you improve
product quality and process efficiency. Complete spray solutions for
pharmaceutical and biopharmaceutical processing including: Vessel
Cleaning, CIP/SIP, Tablet Coating, Spray Drying, Fluid Bed and
Granulation. Meets cGMP and ASME BPE standards. Custom design and
fabrication of nozzles, spray balls and lances.
Company:                   Swiss Pavilion (Swiss Biotech)
Booth:                     2347
Media Contact:             Mr. Domenico Alexakis
Phone:                     41 44 455 56 78
E-mail:                    info@swissbiotech.org
Web:                       www.swissbiotech.org
Switzerland lies at the heart of one of the leading biotechnology
regions, which also encompasses the neighbouring parts of France,
Germany and Italy. Anchored by world-class research of home-based
multinationals Lonza, Novartis, Roche, Merck Serono and Syngenta,
the Swiss biotech industry is among the largest and most diversified
in Europe. This position is reinforced by cutting edge research
carried out in a large and growing network of small and medium-sized
biotech companies throughout the country. Get to know more in the
Swiss Pavilion, Booth no. 2347!
Company:                   Symyx Technologies, Inc.
Booth:                     2002
Ticker Symbol & Exchange:  NASDAQ:SMMX
Media Contact:             Derek Brookmeyer, Racepoint Group
Phone:                     415-694-6702 (direct)
E-mail:                    DBrookmeyer@racepointgroup.com
Web:                       www.symyx.com
Symyx Technologies enables companies in life sciences to transform
scientific R&D and achieve extraordinary breakthroughs in
development speed, productivity and return on investment. The Symyx
Contract Development and Manufacturing Organization (CDMO) for
biopharmaceuticals and will be showcasing its capabilities at BIO.
With expertise in pre-formulation development, formulation
optimization and stability, and analytical method development, the
Symyx CDMO helps biopharmaceutical companies move promising drug
candidates to clinical trials faster and more reliably with
integrated formulation development and CGMP fill/finish clinical
manufacturing. Visit Symyx at Booth 2002 in the BIO IT Zone.
Company:                   Temptime Corporation
Booth:                     5048 in BIONJ 4944
Media Contact:             Emily Moore and Maria Chernock
Phone:                     973-984-6037/201-259-3700
E-mail:                    emilym@temptimecorp.com and mcchernock@aol.com
Web:                       www.temptimecorp.com
Temptime, the world leader in time-temperature indicators, has
devices covering a wide range of time and temperature combinations.
Our patented technology includes HEATmarker(R) and FREEZEmarker(R),
individual unit devices that indicate when product has been exposed
to damaging temperature from the time of manufacture through to
patient administration. In addition, TransTracker box level devices
provide definitive, irreversible readings that are eco-friendly
avoiding the waste associated with battery operated devices.
TransTrackers are the most cost-effective devices compared to
competitors. Temptime has 12 years of success selling billions of
HEATmarkers to pharmaceutical companies globally for vaccines.
Contact Emily Moore (973) 984-6037.
Company:                   Transave Inc.
Media Contact:             Jennifer Corrigan
Phone:                     (732) 742-714
E-mail:               jenn.corrigan@comcast.net
Web:                  www.transaveinc.com
TRANSAVE's mission is to improve the treatment of serious lung
diseases through the company's proprietary advanced pulmonary
liposome technology providing prolonged release of a drug in the
lung while minimizing systemic exposure. The lead compound Arikace
(liposomal amikacin for inhalation) has the potential to
significantly improve the therapeutic index for patients with
chronic lung infections. Positive placebo-controlled Phase II data
were reported in Cystic Fibrosis patients with pseudomonas
infections that included statistically significant improvements in
pulmonary function that were sustained 28 days following treatment.
Phase II data will be available in June of this year for patients
with Non-CF bronchiectasis.
Company:              Validapro BioSciences Inc - Laborium
Booth:                5718
Media Contact:        Luc Dubois
Phone:                450 668-1144
E-mail:               l.dubois@validapro.com
Web:                  www.validapro.com - www.laboriumbio.com
Company:              VWR International, LLC
Booth:                1733
Media Contact:        Valerie Collado
Phone:                610-429-2796
E-mail:               valerie_collado@vwr.com
Web:                  www.vwr.com
VWR International, LLC is a leading global laboratory supply company
with worldwide sales of over $3.5 billion USD. We offer products
from a wide range of manufacturers to a large number of customers
primarily in North America, Europe and Asia. Our principal customers
are major pharmaceutical, biotechnology, industrial and government
organizations as well as universities and schools. We support our
customers by providing a diversified product mix, storeroom
management, product procurement, supply chain systems integration,
technical services, and laboratory bench top delivery. VWR is
headquartered in West Chester, Pennsylvania, and maintains
operations in over 20 countries.
Company:              Women In Bio
Booth:                6041
Media Contact:        Gianna Arnold
Phone:                703-819-7647
E-mail:               womeninbio@comcast.net
Web:                  www.womeninbio.org
Women In Bio (WIB) is a vibrant organization dedicated to the
success of women entrepreneurs, executives, scientists,
professionals, and students in the biotech and life sciences
industry. WIB plans and presents unique and valuable educational
programs that help women build successful companies and foster
professional and personal growth. Our innovative programs include:
1. Education programs and workshops
2. Networking events
3. Professional development seminars
4. Business opportunities for entrepreneurs and executives to meet
investors, attorneys, accountants, marketing executives and human
resource experts
5. Programs on science and entrepreneurship for young women in
middle and high school

About Business Wire

Business Wire, a Berkshire Hathaway company, is utilized by tens of thousands of member companies and organizations worldwide to functionally enhance and communicate investor relations and public relations content to target audiences. As a recognized disclosure service in the United States, Canada and a dozen European countries, Business Wire facilitates the simultaneous flow of market-moving press releases from corporations to financial markets and their audiences, including regulatory authorities, media, investors, financial information systems and consumer news services. Business Wire also handles XBRL tagging, document formatting and regulatory filing into EDGAR, SEDAR, FSA and other systems.

Communications professionals turn to Business Wire to optimize and issue press releases, photos and multimedia to news organizations, journalists, trade publications, search engines, and individuals, with full-text posting to web sites, online services and databases. A range of distribution options enables members to target by geography, industry, news theme and audience demographics.

Founded in 1961, Business Wire has dual headquarters in San Francisco and New York, with 30 bureaus in cities including Los Angeles, Chicago, Boston, Miami, Paris, Frankfurt, London, Brussels, Tokyo, Toronto and Sydney and reciprocal offices throughout the world. Business Wire's patented NX data platform supports XML, XHTML and XBRL code that enhances news release interactivity, social media sharing and search engine optimization. More information about Business Wire and its services is located on its website at www.BusinessWire.com.

SOURCE: Business Wire Global Event Services

Business Wire 
Global Event Services 
310-820-9473 
http://www.businesswire.com 
http://www.tradeshownews.com